Cells change their ribosomes when they receive a danger signal from the immune system, the new study showed. “They change the balance toward a type of ribosome that has a flexible arm sticking out, ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Planned industry first clinical trial combining BeiGene's checkpoint inhibitor tislelizumab with Indaptus’ broadly targeted, short duration ...

Investing in Cabaletta Bio for potential high returns on innovative CAR-T therapies despite volatility and risk. Click here to read an analysis of CABA stock.